Page last updated: 2024-08-16

mitomycin and lidocaine

mitomycin has been researched along with lidocaine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansch, C; Khwaja, TA; Selassie, CD1
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Apple, DJ; Izak, AM; Macky, TA; Pandey, SK; Trivedi, RH; Werner, L1
Colombel, M; Moch, C; Pirot, F; Pivot, C; Rodríguez Armesto, L; Salmon, D1
Li, M; Mi, Z; Ren, L; Xu, J; Yan, L; Yang, X; Zhang, S; Zhao, L1

Reviews

1 review(s) available for mitomycin and lidocaine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for mitomycin and lidocaine

ArticleYear
Structure-activity relationships of antineoplastic agents in multidrug resistance.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured

1990
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
    Biochemical and biophysical research communications, 2004, Mar-19, Volume: 315, Issue:4

    Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Viscoanesthesia. Part I: toxicity to corneal endothelial cells in a rabbit model.
    Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:3

    Topics: Acetates; Anesthetics, Local; Animals; Anthraquinones; Coloring Agents; Drug Combinations; Endothelium, Corneal; Hyaluronic Acid; Lidocaine; Minerals; Mitomycin; Models, Animal; Rabbits; Sodium Chloride; Staining and Labeling; Trypan Blue

2003
Bladder tissue permeability and transport modelling of intravesical alum, lidocaine hydrochloride, methylprednisolone hemisuccinate and mitomycin C.
    International journal of pharmaceutics, 2014, Apr-10, Volume: 464, Issue:1-2

    Topics: Administration, Intravesical; Alum Compounds; Animals; Biological Transport; Lidocaine; Mitomycin; Organ Culture Techniques; Permeability; Swine; Urinary Bladder

2014
Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer.
    Scientific reports, 2018, 01-12, Volume: 8, Issue:1

    Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lidocaine; Mice; Mice, Inbred BALB C; Mitomycin; Treatment Outcome; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2018